1. Despropionylfentanyl
2. Despropionylfentanyl Dihydrochloride
1. 21409-26-7
2. Despropionylfentanyl
3. Depropionylfentanyl
4. Anpp
5. 4-piperidinamine, N-phenyl-1-(2-phenylethyl)-
6. N-phenyl-1-(2-phenylethyl)piperidin-4-amine
7. Despropionyl Fentanyl
8. 4-anilino-1-phenethylpiperidine
9. N-phenyl-1-(2-phenethyl)piperidin-4-amine
10. Q88ehd0u8g
11. 4-anilino-n-phenethyl-piperidine
12. N-phenyl-1-(2-phenylethyl)-4-piperidinamine
13. N-(1-phenethyl-piperidin-4-yl)-aniline
14. 4-anilino-n-phenethyl-4-piperidine
15. N-[1-(2-phenylethyl)-4-piperidinyl]benzenamine
16. 4-anpp
17. Anpp Solution
18. Unii-q88ehd0u8g
19. Fentanyl Related Compound E
20. Oprea1_282173
21. Oprea1_665756
22. Schembl916913
23. 4-anilino-n-phenethylpiperidine
24. Dea No. 8333
25. Discontinued See: A625875
26. 4-anilino N-phenethyl Piperidine
27. Dtxsid40175680
28. Zinc272395
29. Bcp25261
30. Cs-d0504
31. Akos008969276
32. Anpp ( Precursor To Fentanyl)
33. Am62697
34. Ac-25832
35. As-38214
36. Fentanyl Impurity D [ep Impurity]
37. N-(1-phenethyl-4-piperidinyl)-phenylamine
38. 4-anilino-1-(2-phenethyl)piperidine
39. Eu-0037135
40. Fentanyl Related Compound E [usp-rs]
41. Ft-0673808
42. N-phenyl-1-(2-phenylethyl)-4-piperidinamine #
43. N-phenyl-n'-[1-(2-phenylethyl)]-4-piperidine
44. 4-anilino-1-(.beta.-phenethyl)piperidine
45. Fentanyl Citrate Impurity D [ep Impurity]
46. Fentanyl Related Compound E [usp Impurity]
47. N-(1-(2-phenylethyl)-4-piperidinyl)aniline
48. Fentanyl Related Compound E Cii [usp Impurity]
49. Q27287105
50. 4-anpp Solution, 100 Mug/ml In Methanol, Certified Reference Material, Ampule Of 0.5 Ml
Molecular Weight | 280.4 g/mol |
---|---|
Molecular Formula | C19H24N2 |
XLogP3 | 4.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 280.193948774 g/mol |
Monoisotopic Mass | 280.193948774 g/mol |
Topological Polar Surface Area | 15.3 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 271 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
MARKET PLACE
LOOKING FOR A SUPPLIER?